Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
EnzymeBioSystems Create: Alert

All | News | Filings
Date FiledTypeDescription
01/03/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/14/2017 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Form of Common Stock Purchase Warrants-Class A",
"Form of Common Stock Purchase Warrants-Class B",
"Form of Common Stock Purchase Warrants-Class C",
"Form of Common Stock Purchase Cashless Warrants-Class D",
"Securities Purchase Agreement"
10/02/2017 8-K Quarterly results
01/17/2017 8-K Form 8-K - Current report
10/13/2015 8-K Changes in Registrant's Certifying Accountant, Other Events, Financial Statements and Exhibits
09/25/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/20/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "EnzymeBioSystems PRODUCT DEVELOPMENT UPDATE Las Vegas, NV, August 20, 2015 – EnzymeBioSystems announces that while it continues its early-stage research to obtain an Investigational New Drug Application for methyl amooranin, a product the prevention of breast cancer, management is pursuing other opportunities for the Company. Management has been working on developing proprietary OTC product to be sold under the EnzymeBioSystems label. There are a number of ideas in process, management has not limited itself to any particular OTC product idea. This includes sleep remedies, cough cold products, and skin care products. "As a precautionary note, there are no assurances that the company will ever be able to develop an OTC product were a we can obtain distribution or market acceptance," stated M..."
10/23/2014 8-K Appointed CFO
06/13/2014 8-K Unregistered Sales of Equity Securities, Other Events
06/05/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/05/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Purchase Agreement between EnzymeBioSystems and Berkeley Clinic, LC"
02/01/2011 8-K Form 8-K - Current report
05/06/2010 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy